Cargando…

Hospital‐at‐home care for immunodeficient patients with COVID‐19: Approach to persistent COVID‐19 infection

KEY CLINICAL MESSAGE: Patients with COVID‐19 who have undergone B‐cell depletion therapy could have prolonged SARS‐CoV‐2 infection; therefore, even in the hospital‐at‐home setting, primary care physicians should carefully consider the treatment regimen and the timing of ending isolations in such cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Yuki, Matsumura, Yasufumi, Sumiyoshi, Shougen, Morikami, Yoshiki, Nagao, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160423/
https://www.ncbi.nlm.nih.gov/pubmed/37151938
http://dx.doi.org/10.1002/ccr3.7294
Descripción
Sumario:KEY CLINICAL MESSAGE: Patients with COVID‐19 who have undergone B‐cell depletion therapy could have prolonged SARS‐CoV‐2 infection; therefore, even in the hospital‐at‐home setting, primary care physicians should carefully consider the treatment regimen and the timing of ending isolations in such cases, and should not hesitate to consult with infectious disease specialists if necessary. ABSTRACT: We presented the first reported case of hospital‐at‐home care for a patient with persistent COVID‐19 who had undergone B‐cell depletion therapy. He received hospital‐at‐home care, including two courses of remdesivir; however, he ultimately failed to recover and was transferred to the hospital.